06485729 is referenced by 11 patents.

An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine composition provides protection in a host, animal or human, against influenza infection, including viral replication and systemic infection. Oral, nasal or other mucosal or per needle administration, including intracutaneous, intradermal, intramuscular, intravascular, and intravenous, are included.

Title
Neuraminidase-supplemented compositions
Application Number
9/372734
Publication Number
6485729 (B1)
Application Date
August 11, 1999
Publication Date
November 26, 2002
Inventor
Franklin Volvovitz
Woodbridge
CT, US
Craig S Hackett
Wallingford
CT, US
Andrei I Voznesensky
West Hartford
CT, US
Bethanie E Wilkinson
Higganum
CT, US
Bert E Johansson
Armonk
NY, US
Edwin D Kilbourne
Madison
CT, US
James T Matthews
Allamuchy
NJ, US
Gail Eugene Smith
Wallingford
CT, US
Agent
Frommer Lawrence & Haug
US
Agent
Thomas J Kowalski
US
William S Frommer
US
Assignee
Protein Sciences Corporation
CT, US
IPC
A61K 39/145
View Original Source